OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth

Rimon client, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of regulatory-grade Real World Data (“iRWD™”), through its proven OneMedNet iRWD™ solution, today announced that it has entered into a definitive securities purchase agreement as of March 28, 2024 with an institutional investor providing up to $4.54 million in funding through a private placement for the issuance of senior convertible notes. OneMedNet intends to use the net proceeds when received from the offering for working capital purposes.

Rimon acted as legal counsel to OneMedNet Corporation on the Notes Offering led by Partner, Debbie Klis, with support from Partner, Carl Sherer.

Congratulations to OneMedNet Corporation on this milestone!

Read the press release here.

Rimon’s Securities and Capital Markets attorneys have decades of experience representing sponsors, issuers, investment banks, underwriters, and shareholders operating across a wide variety of industries in connection with major securities offerings as well as regulatory and compliance issues.  As a truly global firm, we have attorneys located in all the key international financial centers and have extensive experience representing our clients in cross-border capacities. Read more here.